Correlation Between Merck KGaA and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck KGaA and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck KGaA and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck KGaA ADR and Bionoid Pharma, you can compare the effects of market volatilities on Merck KGaA and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck KGaA with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck KGaA and Bionoid Pharma.

Diversification Opportunities for Merck KGaA and Bionoid Pharma

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Merck and Bionoid is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Merck KGaA ADR and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Merck KGaA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck KGaA ADR are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Merck KGaA i.e., Merck KGaA and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Merck KGaA and Bionoid Pharma

Assuming the 90 days horizon Merck KGaA ADR is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, Merck KGaA ADR is 27.98 times less risky than Bionoid Pharma. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  100.00  in Bionoid Pharma on November 2, 2024 and sell it today you would lose (72.00) from holding Bionoid Pharma or give up 72.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Merck KGaA ADR  vs.  Bionoid Pharma

 Performance 
       Timeline  
Merck KGaA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck KGaA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Merck KGaA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Bionoid Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Merck KGaA and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck KGaA and Bionoid Pharma

The main advantage of trading using opposite Merck KGaA and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck KGaA position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Merck KGaA ADR and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data